MEMOREXA (2) (tm)
Natural health product licensed in Canada
- Other names
- KONIG NEURO MAXIMIZER (3 tm), KONIG NEUROX (2) (tm), NEURO MAXIMIZER (3) (tm), NEUROMAX (2) (tm), NEUROX (2) (tm)
- Licence holder
- Provita Nutrition and Health Inc.
- NPN or DIN-HM
- 80091365
- Status
- Active licence
- Licence date
- 19 March 2019
- Revision date
- Not provided
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
- Conditions légales
Ginkgo biloba L.: L'étiquetage des compléments alimentaires qui contiennent la feuille de la plante Ginkgo biloba L. doit comporter un avertissement avec la teneur suivante: "Consultez votre médecin en cas de prise simultanée d'anticoagulants."
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Acide 2-aminoéthanesulfonique Source : Taurine | 50 mg | Not calculated |
| Acide (±)-1,2-dithiolane-3-pentanoïque Source : Acide DL-alpha-lipoÏque | 50 mg | Not calculated |
| Ginkgo biloba Source : Feuille Extract : Matériel brut sec Extraction ratio : 50:1 Dry plant equivalent : 2,000 mg Potency : 6 % Terpene lactones | 40 mg | Not calculated |
| Hericium erinaceus Source : Corps fructifère Extract : Matériel brut sec Extraction ratio : 10:1 Dry plant equivalent : 1,000 mg | 100 mg | Not calculated |
| Sel interne de (2R)-2-(Acétyloxy)-3-carboxy-N,N,N-triméthyl-1-propanaminium Source : N-acétyl L-chlorhydrate de carnitine | 100 mg | Not calculated |
| Phosphatidylsérine Source : Lécithine de soja enrichie en phosphatidylsérine | 12.5 mg | Not calculated |
Non-medicinal ingredients
Stéarate de magnésium, Hypromellose, Palmitate d'ascorbyle, Cellulose microcristalline
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 19 years | 2 Capsule | 1 Tous les jours |
Uses authorised in Canada
Helps to enhance cognitive function and memory in adults. Provides antioxidants for the maintenance of good health.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Effets indésirables connus
May cause digestive problems.
Source
Official Health Canada record, licence 80091365
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.